Recent-onset rheumatoid arthritis: A 1-year observational study of correlations between health-related quality of life and clinical/laboratory data

被引:27
作者
Thyberg, I
Skogh, T
Hass, UAM
Gerdle, B
机构
[1] Linkoping Univ, Fac Hlth Sci, AIR, Dept Mol & Clin Med,Div Rheumatol, S-58183 Linkoping, Sweden
[2] Linkoping Univ, Swedish Inst Disabil Res, S-58183 Linkoping, Sweden
[3] Univ Orebro, Swedish Inst Disabil Res, Orebro, Sweden
[4] Univ Orebro, Dept Clin Med, Orebro, Sweden
[5] Linkoping Univ, Dept Hlth & Soc, Ctr Med Technol Assessment, S-58183 Linkoping, Sweden
[6] Linkoping Univ, Fac Hlth Sci, Dept Neurosci & Locomot, Div Rehabil Med, S-58183 Linkoping, Sweden
[7] Linkoping Univ Hosp, Pain & Rehabil Ctr, S-58185 Linkoping, Sweden
关键词
outcome; early rheumatoid arthritis; health-related quality of life; HAQ; SF-36; grip force; walking speed;
D O I
10.1080/16501970410023344
中图分类号
R49 [康复医学];
学科分类号
100215 [康复医学与理疗学];
摘要
Objective: To analyse correlations within and between clinical/laboratory assessments and health-related quality of life variables for recent-onset rheumatoid arthritis at the time of diagnosis and 12 months later. Methods: A total of 297 patients with recent-onset (5512 months) rheumatoid arthritis were included at diagnosis and followed up for 12 months. Clinical/laboratory assessment was performed by erythrocyte sedimentation rate, C-reactive protein, 28-joint count of tender/swollen joints, physician's global assessment, grip force, grip ability, functional impairment and walking speed. The self-reported health-related quality of life included symptoms (pain, morning stiffness), patients estimated general health, Health Assessment Questionnaire and SF-36. Results: All tested variables improved within 6 months of diagnosis and then remained stable but still affected at the 12-month follow-up. Multivariate correlations between clinical/laboratory variables and health-related quality of life were weak. At inclusion, clinical/laboratory assessments explained 18% of health-related quality of life at the same time-point and predicted 7% of the variation in health-related quality of life after 12 months. Conclusion: The time-course followed similar patterns for most variables, but only a small part of the variation in health-related quality of life was explained or predicted by the clinical/laboratory variables. This implies that health-related quality of life adds important information to clinical/laboratory assessments in clinical practice and should be considered in goal setting together with clinical/laboratory assessment in order to optimize healthcare and outcome.
引用
收藏
页码:159 / 165
页数:7
相关论文
共 34 条
[1]
THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]
BIJLSMA JWJ, 1991, J RHEUMATOL, V18, P650
[3]
How does the short form 36 health questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population values? A cross-sectional study [J].
Birrell, FN ;
Hassell, AB ;
Jones, PW ;
Dawes, PT .
CLINICAL RHEUMATOLOGY, 2000, 19 (03) :195-199
[4]
Outcome measures, pooled index and quality of life instruments in rheumatoid arthritis [J].
Cheah, SY ;
Clark, C ;
Goldberg, L ;
Po, ALW ;
Phillips, R .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1996, 21 (05) :297-316
[5]
DELLHAG B, 1995, J RHEUMATOL, V22, P1559
[6]
EBERHARDT KB, 1988, BRIT J RHEUMATOL, V27, P364
[7]
ASSESSING DISABILITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS - USE OF A SWEDISH VERSION OF THE STANFORD HEALTH ASSESSMENT QUESTIONNAIRE [J].
EKDAHL, C ;
EBERHARDT, K ;
ANDERSSON, SI ;
SVENSSON, B .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1988, 17 (04) :263-271
[8]
Eriksson E, 2002, HLTH HLTH RELATED QU
[9]
Eriksson L., 1999, INTRO MULTI MEGAVARI
[10]
Escalante A, 1999, ARTHRITIS RHEUM-US, V42, P1712, DOI 10.1002/1529-0131(199908)42:8<1712::AID-ANR21>3.0.CO